Skip to main content

Table 1 Patient characteristics and comparison between patients who did and did not achieve the PK/PD target of 100% f T>MIC and 50% f T>MIC. Data are reported as median (interquartile range).

From: Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

Variable

All patients (n = 60)

PK/PD target (100% f T>MIC) achieved (n = 33/60) (55%)

PK/PD target (100% f T>MIC) not achieved (n =27/60) (45%)

P value

PK/PD Target (50% f T>MIC) achieved (n = 43/52) (86%)

PK/PD target (50% f T>MIC) not achieved (n=7/52) (14%)

P value

Male gender (n, %)

51 (85%)

28 (84%)

23 (85%)

0.721

36 (84 %)

7 (100%)

0.330

Age (years)

56 (48-67)

61 (53-73)

51(30-60)

0.016

60 (52-72)

48 (25-67)

0.054

Weight (kg)

78 (69-90)

75 (65-81)

83 (75-90)

0.014

75 (66-85)

85 (75-90)

0.041

Height (m)

1.75 (1.70-1.80)

1.75 (1.67-1.79)

179 (1.72-1.80)

0.170

1.74 (1.68-1.80)

1.79 (1.75-1.80)

0.098

BMI

25 (22-28)

24 (22-27)

25 (24-29)

0.084

24 (22-27)

25 (25-28)

0.188

SOFA at the day of study

5 (3-7)

5 (2-8)

5 (3-6)

0.693

5 (3-8)

4 (2-6)

0.358

Serum creatinine concentration (μmol/L)

54 (43-75)

53 (44-79)

56 (41 - 64)

0.623

57 (44-76)

54 (38-59)

0.306

Creatinine clearance (mL/min)

 

104 (87-123)

165 (138-208)

<0.001

106 (91-143)

215 (190-246)

<0.001

Antibiotic used

   Meropenem (n, %)

   Piperacillin (n, %)

17 (30%)

43 (70%)

7/17 (41%)

25/43 (58%)

10/17 (59%)

18/43 (42%)

0.24

9/11 (82 %)

33/41 (80 %)

2/11 (18 %)

8/41 (20 %)

0.515

  1. SOFA: Sequential Organ Failure Assessment.